Electrical Stimulation Devices Market Report 2026

Electrical Stimulation Devices Market Overview

• Electrical Stimulation Devices market size has reached to $8.43 billion in 2025 • Expected to grow to $13.22 billion in 2030 at a compound annual growth rate (CAGR) of 9.3% • Growth Driver: Rising Prevalence Of Muscle Disorders Fuels Growth In The Electrical Stimulation Devices Market • Market Trend: Electrical Stimulation Device Makers Advance Innovation With High-Definition Neuromodulation Technologies • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Electrical Stimulation Devices Market?

Electrical stimulation devices are modest electrical devices attached to the skin with electrodes and worn externally by patients used for lowering acute post-operative pain and swelling, treating chronic intractable pain. It is a device use to emit gentle electrical pulses through the skin useful in treating a variety of nerve and musculoskeletal pain disorders. The main types of electrical stimulation devices include deep brain stimulation devices, neuromuscular electrical stimulation devices, sacral nerve stimulation devices, spinal cord stimulation devices and others. Deep brain stimulation devices refer to a medical treatment that uses an implanted device to deliver an electrical current to specific areas of the brain, used for the treatment of movement disorders associated with Parkinson's disease (PD), dystonia, essential tremors, and other neurological conditions. These are used for various applications including pain management, neurological & movement disorder management, musculoskeletal disorder management, metabolism, GIT management and others, used by hospitals, ambulatory surgical centers and others.

What Is The Electrical Stimulation Devices Market Growth Forecast?

The electrical stimulation devices market size is expected to see strong growth in the next few years. It will grow to $13.22 billion in 2030 at a compound annual growth rate (CAGR) of 9.3%. The growth in the forecast period can be attributed to increasing adoption of personalized neuromodulation treatments, rising investments in smart implantable devices, expansion of outpatient pain management procedures, growing focus on remote device monitoring, increasing demand for advanced neurological therapies. Major trends in the forecast period include increasing adoption of implantable neurostimulation devices, rising demand for non-invasive pain management solutions, growing integration of smart control systems, expansion of neuromodulation therapies, enhanced focus on patient-specific treatment protocols.

Global Electrical Stimulation Devices Market Segmentation

1) By Device Type: Neuromuscular Electrical Stimulation Devices, Spinal Cord Stimulation Devices 2) By Application: Pain Management, Musculoskeletal Disorder Management 3) By End User: Hospitals, Ambulatory Surgical Centers Subsegments: 1) By Neuromuscular Electrical Stimulation Devices: Transcutaneous Electrical Nerve Stimulators (TENS), Functional Electrical Stimulation (FES) Devices, Surface Electrode Systems 2) By Spinal Cord Stimulation Devices: Implantable Pulse Generators, Leads, Battery Systems

What Is The Driver Of The Electrical Stimulation Devices Market?

The increasing prevalence of muscle disorders is expected to propel the growth of the electrical stimulation devices market forward. Muscular disorders are a set of inherited genetic illnesses that produce muscle weakness over time. These muscle disorders may cause weakness or paralysis in the presence of an intact nervous system. Electrical stimulation devices help to reduce muscle weakness, producing a controlled and comfortable muscular contraction using skin electrodes and a portable stimulator. For instance, in January 2024, according to the GOV.UK, a UK-based government department, in 2023, 18.4% of individuals aged 16 and older reported having a long-term musculoskeletal (MSK) condition, marking an increase from the 17.6% prevalence recorded in 2022. Therefore, the increasing prevalence of muscle disorders is subsequently propelling the electrical stimulation devices industry.

Key Players In The Global Electrical Stimulation Devices Market

Major companies operating in the electrical stimulation devices market are Boston Scientific Corporation, Abbott Laboratories, DJO Global Inc., BTL Corporate Inc., Nevro Corp., NeuroMetrix Inc., Zynex Inc., BioMedical Life Systems, RS Medical, Beijing Pins Medical Co. Ltd., MicroPort Scientific Corporation, Soterix Medical Inc., Medtronic plc, MYOLYN, Cyberonics Inc., Stimwave Technologies, EndoStim Inc., SPR Therapeutics, Nuvectra Corporation, ElectroCore Inc., Axonics Modulation Technologies Inc., Inspire Medical Systems Inc.

Global Electrical Stimulation Devices Market Trends and Insights

Major companies operating in the electrical stimulation devices market are focusing on developing innovative solutions, such as high-definition transcranial electrical stimulation (HD-tES) integrated with wireless EEG monitoring. HD-tES is a non-invasive electrical neuromodulation approach that uses multiple, precisely controlled small electrodes to shape current flow and target specific cortical regions with higher spatial resolution than traditional two-pad Tdcs. For instance, in May 2024, Soterix Medical Inc., a US-based medical device manufacturing company, launched the MxN-GO EEG system, an integrated, wire-free HD-tES plus EEG platform. The MxN-GO EEG system is built as a lightweight, untethered headset combining 33 stimulation channels with 32 recording channels to allow simultaneous high-definition stimulation and real-time EEG capture; it uses modular electrode arrays and an on-device controller for rapid set-up and programmable multi-site waveforms. Functionally, the system enables precise spatial targeting, synchronized stimulation/recording for research or clinical protocols, and portability for clinic or bedside use.

What Are Latest Mergers And Acquisitions In The Electrical Stimulation Devices Market?

In September 2023, Amber Therapeutics Ltd., a UK-based healthcare technology company, acquired Bioinduction Limited for an undisclosed amount. With this acquisition, Amber Therapeutics Ltd., gained full control of the development and manufacturing of the Picostim-based hardware to accelerate the development and commercialization of its Amber-UI neuromodulation therapy and to build out a broader portfolio of adaptive neurostimulation technologies. Bioinduction Limited is a UK-based medical device/technology company that specializes in implantable, closed-loop neuromodulation systems.

Regional Outlook

North America was the largest region in the electrical stimulation devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the electrical stimulation devices market report during the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Electrical Stimulation Devices Market?

The electrical stimulation devices market consists of sales of implantable electronic stimulation devices, vagus nerve stimulation (VNS) devices and transcutaneous electrical nerve stimulation (TENS) devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.